1)  cardioplegia
温血连灌
1.
ObjectiverTo clinically evaluate the myocardial protective effects of leukocyte-depleted blood cardioplegia (LDBCP) in valve replacement patients.
除实验组在温血连灌通路上加用中性粒细胞滤器(LDF)脱去中性粒细胞，制成脱中性粒细胞温血心脏停搏液外，其它术中处理两组均相同。
2)  Wenxue (warm blood)
温血
1.
Discussion on atmosphere and Wenxue (warm blood);
关于“大气”与“温血”——《素问·离合真邪论篇》析疑二则
3)  infants
温血诱导
1.
Objective:To investgate the myocardium protection of warm induction and continuous perfusion cold blood cardioplegia on infants.
目的:探讨温血诱导心停搏加冷血停搏液持续灌注对婴幼儿心脏手术的心肌保护作用。
4)  warm blood cardioplegic solution
温血灌注
1.
One is Group I(WBC), who received warm blood cardioplegic solution modified by full or half potassium, and the other is Group II(CCC), who received cold crystalloid cardiopleg.
目的　研究心脏手术麻醉过程中温血灌注液和冷晶体灌注液对心肌的保护作用。
5)  Warm blood hyperkalemia
温血高钾
6)  warm blood
氧合温血
1.
Objective: To examine the cardioprotection efficacy of warm blood cardioplegia in patients undergoing open heart surgery.
目的:观察氧合温血停搏液对心脏直视手术缺血期间的心肌保护作用。
参考词条
补充资料：目血灌瞳人
目血灌瞳人 目血灌瞳人 　　病证名。见《圣济总录》卷一百零五。即血灌瞳人。详该条。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。